Jamie Reed
Gender clinic whistleblower and case manager
Jamie Reed spent four years as a case manager inside Washington University's Transgender Center at St. Louis Children's Hospital — one of America's busiest paediatric gender clinics. When she blew the whistle in 2023, her testimony triggered investigations across the United States and sent shockwaves through a Europe that was already beginning to question the model she knew from the inside.
Jamie Reed worked as a case manager at Washington University's Transgender Center at St. Louis Children's Hospital for four years, coordinating care and processing referrals in one of America's busiest paediatric gender clinics. In late 2022 she filed a whistleblower complaint with Missouri's attorney general; in early 2023 she published a detailed account in The Free Press describing how an affirmation-only culture had displaced clinical rigour. The disclosure prompted state-level investigations, congressional testimony, and a national debate about oversight standards in paediatric gender medicine.
Reed appeared on the Beyond Gender podcast in the episode Gender Clinic Whistleblower Thought She Was Helping Kids but She Was Wrong (episode 49, November 2025), in conversation with hosts Stella O'Malley, Mia Hughes, and Dr Bret Alderman. She described the internal dynamics of a busy gender clinic — the pace of referrals, the pressure not to question diagnoses, and the absence of systematic long-term follow-up — in terms that European clinicians and policymakers will recognise from their own reassessment processes.
Her account arrives at a pivotal moment for European policy. Sweden, Finland, Norway, and France have each introduced restrictions on paediatric gender medicine following systematic reviews that found evidence of benefit weak and potential harms real. The Netherlands — birthplace of the Dutch Protocol that underpinned affirmative care globally — is now revisiting that same model. Reed's practitioner-level testimony offers the kind of granular, insider evidence that formal evidence reviews can struggle to surface.
For European patients, families, clinicians, and regulators, her story is a pointed reminder that institutional momentum and individual conscience can pull in opposite directions — and that whistleblowers tend to bear a disproportionate share of the cost when they do.
